13F-HR: Ventas, Inc. Discloses $159.6 Million Investment in Ardent Health Partners
Form 13F Holdings Report
Ventas, Inc. reports a $159.6 million investment in Ardent Health Partners as of December 31, 2024.
Summary
- Ventas, Inc. filed a Form 13F report for the quarter ended December 31, 2024.
- The report discloses a holding in Ardent Health Partners Inc. Common Stock.
- The total value of the holding is $159,569,917.
- Ventas, Inc. holds 9,342,501 shares of Ardent Health Partners Inc.
- Robert F. Probst, Executive Vice President and Chief Financial Officer of Ventas, Inc., signed the report on February 13, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Positives
- The disclosure provides transparency into Ventas, Inc.'s investment portfolio.
Risks
- The value of the investment in Ardent Health Partners is subject to market fluctuations.
Industry Context
Institutional investment managers are required to file Form 13F to disclose their equity holdings, providing insights into investment trends and strategies within the market.
Stakeholder Impact
- Shareholders of Ventas, Inc. are informed about the company's investment in Ardent Health Partners.
- Ardent Health Partners' stakeholders may be interested in the level of investment from Ventas, Inc.
Key Dates
| Date | Description |
|---|---|
| 12-31-2024 | Report for the Calendar Year or Quarter Ended |
| 02-13-2025 | Date of Signing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.